Acasti pharma inc. ceo, jan d'alvise, is featured on the stock day podcast

Phoenix, arizona--(newsfile corp. - february 22, 2022) - the stock day podcast welcomed acasti pharma inc. (nasdaq: acst) ("the company"), a specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. ceo of the company, jan d'alvise, joined stock day host everett jolly. jolly began the interview by asking about the company's background and current projects. "acasti is a specialty pharma company," explained d'alvise. "we have developed a range of...
ACST Ratings Summary
ACST Quant Ranking